Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors. | FEBS Open Bio | 2022 | 35612789 | PubTator, text mining | PubMed |
| A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. | Neuro Oncol | 2022 | 35609559 | PubTator, text mining | PubMed |
| Diffuse large B cell lymphoma and a novel gammaherpesvirus in northern elephant seals Mirounga angustirostris. | Dis Aquat Organ | 2022 | 35608510 | PubTator, text mining | PubMed |
| Revealing the Longevity Code of Humans with up to Extreme Longevity in Guangxi Based on Physical Examination Indicators and Personalized Biomarkers of Aging. | Biomed Res Int | 2022 | 35607300 | PubTator, text mining | PubMed |
| Single cell analysis reveals intra-tumour heterogeneity, microenvironment and potential diagnosis markers for clear cell renal cell carcinoma. | Clin Transl Med | 2022 | 35605062 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications. | Int J Cancer | 2022 | 35603909 | PubTator, text mining | PubMed |
| Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-κB/NLRP3 Signaling. | Front Immunol | 2022 | 35603205 | PubTator, text mining | PubMed |
| Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer. | Front Immunol | 2022 | 35603186 | PubTator, text mining | PubMed |
| Macrophage: A Cell With Many Faces and Functions in Tuberculosis. | Front Immunol | 2022 | 35603185 | PubTator, text mining | PubMed |
| M-CSFR expression in the embryonal component of hepatoblastoma and cell-to-cell interaction between macrophages and hepatoblastoma. | Med Mol Morphol | 2022 | 35597882 | PubTator, text mining | PubMed |
| Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer. | Sci Rep | 2022 | 35595859 | PubTator, text mining | PubMed |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. | Sci Rep | 2022 | 35595798 | PubTator, text mining | PubMed |
| Integrating single-cell RNA sequencing with spatial transcriptomics reveals immune landscape for interstitial cystitis. | Signal Transduct Target Ther | 2022 | 35589692 | PubTator, text mining | PubMed |
| SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer. | BMC Cancer | 2022 | 35578316 | PubTator, text mining | PubMed |
| Modulation of Cholesterol Pathways in Human Macrophages Infected by Clinical Isolates of Leishmania infantum. | Front Cell Infect Microbiol | 2022 | 35573792 | PubTator, text mining | PubMed |
| A Dual Role of Complement Activation in the Development of Fulminant Hepatic Failure Induced by Murine-Beta-Coronavirus Infection. | Front Cell Infect Microbiol | 2022 | 35573780 | PubTator, text mining | PubMed |
| Residues 140-142, 199-200, 222-223, and 262 in the Surface Glycoprotein of Subgroup A Avian Leukosis Virus Are the Key Sites Determining Tva Receptor Binding Affinity and Infectivity. | Front Microbiol | 2022 | 35572683 | PubTator, text mining | PubMed |
| Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma. | Front Immunol | 2022 | 35572545 | PubTator, text mining | PubMed |
| Potential Biomarkers and Drugs for Nanoparticle-Induced Cytotoxicity in the Retina: Based on Regulation of Inflammatory and Apoptotic Genes. | Int J Environ Res Public Health | 2022 | 35565057 | PubTator, text mining | PubMed |
| Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma. | J Transl Med | 2022 | 35562760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=50